心力衰竭中神经激素调节的病理生理学理由和临床证据,使用保存的喷射分数
Vincenzo Castiglione1,2, Francesco Gentile2, Nicolò Ghionzoli3
1Interdisciplinary Research Center Health Science, Scuola Superiore Sant'Anna Pisa, Italy.
Cardiac failure review
|July 10, 2023
概括
保存喷射分数 (HFpEF) 的心力衰竭涉及神经激素激活. 目前的疗法显示出有限的预后益处,除了可能在特定的患者子组.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 保存喷射分数的心力衰竭 (HFpEF) 是一种由心脏问题,并发症和衰老影响的复杂综合征.
- HFpEF表现出神经激素轴激活,包括renin-angiotensin-aldosterone和交感神经系统.
- 这种神经激素激活表明HFpEF的治疗点.
研究的目的:
- 审查HFpEF中神经激素调节的病理生理基础.
- 讨论针对HFpEF中神经激素轴的药理和非药理治疗的临床证据.
- 评估当前对HFpEF管理中的神经激素调节的建议.
主要方法:
- 随机临床试验和相关研究的文献综述.
- 对HFpEF背后的病理生理机制的分析.
- 综合治疗干预的临床证据.
主要成果:
- 随机试验在很大程度上未能显示HFpEF中神经激素调节的预后益处.
- 对于左心室喷射分数在正常的下端的患者来说,可能存在潜在的益处.
- 目前的指导方针建议在特定的HFpEF患者群体中考虑这些疗法.
结论:
- 在HFpEF中神经激素调节缺乏广泛的预后证据.
- 治疗策略需要改进,可能针对特定的患者表型.
- 需要进一步的研究来优化HFpEF治疗.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure V: Medical Management
14
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
14
Heart Failure VII: Nursing Interventions
99
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
99
Heart Failure I: Introduction
20
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
20


